Alpha 2.0
Login Register
» Authors » M Remberger

M Remberger

Explore the profile of M Remberger including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 135
Citations 1811
Followers 0
Related Specialties
General Surgery
Hematology
Microbiology
Top 10 Co-Authors
O Ringden
J Mattsson
P Ljungman
J Aschan
H Hagglund
B Lonnqvist
S Carlens
J Winiarski
M Uzunel
A H Neilson
Published In
Bone Marrow Transplant
Transplant Proc
Appl Environ Microbiol
Blood
Transplantation
Affiliations
Soon will be listed here.
Recent Articles
1.
The CD34 Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
Remberger M, Gronvold B, Ali M, Mattsson J, Egeland T, Lundin K, et al.
Clin Hematol Int . 2021 Oct; 2(2):74-81. PMID: 34595446
The effect of CD34 cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft--host disease (GvHD) has not been established...
2.
Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival
Ali M, Gronvold B, Remberger M, Abrahamsen I, Myhre A, Tjonnfjord G, et al.
Clin Lymphoma Myeloma Leuk . 2021 Jun; 21(9):598-605. PMID: 34158268
Anti-thymocyte globulin (ATG) is commonly used to prevent graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). To evaluate the impact of ATG as part of the GvHD prophylaxis...
3.
HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation
Gronvold B, Ali M, Remberger M, Mattsson J, Egeland T, Lundin K, et al.
Bone Marrow Transplant . 2020 Feb; 55(8):1658-1661. PMID: 32054997
No abstract available.
4.
Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors
Wang T, Remberger M, Axdorph Nygell U, Sundin M, Bjorklund A, Mattsson J, et al.
Transfusion . 2018 Mar; 58(6):1442-1451. PMID: 29536557
Background: The composition of the graft used for allogeneic hematopoietic stem cell transplantation (HSCT) is important for the treatment outcome. Different apheresis devices may yield significant differences in peripheral blood...
5.
Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients
Gaballa A, Norberg A, Stikvoort A, Mattsson J, Sundberg B, Uzunel M, et al.
Bone Marrow Transplant . 2017 Oct; 53(1):69-77. PMID: 28991250
Reconstitution of the adaptive immune system following allogeneic hematopoietic stem cell transplantation is crucial for beneficial outcome and is affected by several factors, such as GvHD and graft source. The...
6.
High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis
Remberger M, Afram G, Sundin M, Uhlin M, LeBlanc K, Bjorklund A, et al.
Bone Marrow Transplant . 2016 Jun; 51(11):1518-1521. PMID: 27272449
No abstract available.
7.
Music therapy can lower the heart rates of severely sick children
Uggla L, Bonde L, Svahn B, Remberger M, Wrangsjo B, Gustafsson B
Acta Paediatr . 2016 Apr; 105(10):1225-30. PMID: 27129139
Aim: Paediatric recipients of haematopoietic stem cell transplants (HSCT) are at increased risk of developing post-traumatic stress disorder (PTSD), and there is a need to identify interventions that can alleviate...
8.
Bone marrow aspiration technique has deteriorated in recent years
Remberger M, Ringden O, Mattsson J
Bone Marrow Transplant . 2015 Apr; 50(7):1007-9. PMID: 25893451
No abstract available.
9.
Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation
Hagglund H, Remberger M, Ringden O
Bone Marrow Transplant . 2014 Sep; 49(12):1541-2. PMID: 25243627
No abstract available.
10.
Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy
Solders M, Martin D, Andersson C, Remberger M, Andersson T, Ringden O, et al.
Bone Marrow Transplant . 2014 May; 49(8):1046-51. PMID: 24797185
In metachromatic leukodystrophy (MLD), the deficiency of the lysosomal enzyme arylsulfatase A (ARSA) leads to demyelination in the central and peripheral nervous system and ultimately to death. Allogeneic hematopoietic SCT...